Journey Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.9M | Sell |
22,918
-556
| -2% | -$433K | 1.39% | 14 |
|
|
2025
Q1 | $19.4M | Sell |
23,474
-1,331
| -5% | -$1.1M | 1.59% | 11 |
|
|
2024
Q4 | $22.5M | Hold |
24,805
| – | – | 2.69% | 9 |
|
|
2024
Q3 | $22.5M | Sell |
24,805
-12
| -0% | -$10.9K | 2.69% | 9 |
|
|
2024
Q2 | $22.5M | Sell |
24,817
-4,623
| -16% | -$4.19M | 2.69% | 9 |
|
|
2024
Q1 | $22.9M | Buy |
29,440
+622
| +2% | +$484K | 2.82% | 6 |
|
|
2023
Q4 | $16.8M | Sell |
28,818
-290
| -1% | -$169K | 2.28% | 9 |
|
|
2023
Q3 | $15.6M | Sell |
29,108
-499
| -2% | -$268K | 2.34% | 9 |
|
|
2023
Q2 | $13.9M | Sell |
29,607
-719
| -2% | -$337K | 2.07% | 10 |
|
|
2023
Q1 | $10.4M | Buy |
30,326
+1,461
| +5% | +$502K | 1.63% | 15 |
|
|
2022
Q4 | $10.6M | Buy |
28,865
+3,900
| +16% | +$1.43M | 2.63% | 5 |
|
|
2022
Q3 | $8.07M | Buy |
24,965
+2,251
| +10% | +$728K | 2.06% | 9 |
|
|
2022
Q2 | $7.36M | Buy |
22,714
+4,497
| +25% | +$1.46M | 1.69% | 10 |
|
|
2022
Q1 | $5.22M | Buy |
18,217
+1,866
| +11% | +$534K | 1.32% | 15 |
|
|
2021
Q4 | $4.52M | Buy |
16,351
+499
| +3% | +$138K | 1.25% | 17 |
|
|
2021
Q3 | $3.66M | Sell |
15,852
-380
| -2% | -$87.8K | 1.19% | 19 |
|
|
2021
Q2 | $3.73M | Buy |
16,232
+405
| +3% | +$93K | 1.18% | 18 |
|
|
2021
Q1 | $2.96M | Buy |
15,827
+409
| +3% | +$76.4K | 1.03% | 25 |
|
|
2020
Q4 | $2.6M | Buy |
+15,418
| New | +$2.6M | 0.97% | 29 |
|